{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:50:24Z","timestamp":1761310224045,"version":"3.32.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.pt.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T08:49:10Z","timestamp":1106988550000},"page":"126-132","source":"Crossref","is-referenced-by-count":13,"title":["Satoshi \u014cmura: in pursuit of nature's bounty"],"prefix":"10.1016","volume":"21","author":[{"given":"Andy","family":"Crump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Otoguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/MMBR.50.3.259-279.1986","article-title":"Philosophy of new drug discovery","volume":"50","author":"\u014cmura","year":"1986","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.pt.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7164\/antibiotics.25.473","article-title":"Studies on penicillinase inhibitors produced by microorganisms","volume":"25","author":"Hata","year":"1972","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.pt.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.7164\/antibiotics.32.978","article-title":"Studies on bacterial cell wall inhibitors. VI. Screening method for the specific inhibitors of peptidogylcan synthesis","volume":"32","author":"\u014cmura","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.pt.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2323\/jgam.30.377","article-title":"Two new species of the genus Kitasatosporia, Kitasatosporia phosalacinea sp. nov. and Kitasatosporia griseola sp. nov","volume":"30","author":"Takahashi","year":"1984","journal-title":"J. Genet. Appl. Microbiol."},{"key":"10.1016\/j.pt.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1039\/P19740001627","article-title":"Structure of prumycin","volume":"0","author":"\u014cmura","year":"1974","journal-title":"J. Chem. Soc. (Perkin)"},{"key":"10.1016\/j.pt.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.7164\/antibiotics.36.1783","article-title":"The structure of virustomycin A","volume":"36","author":"\u014cmura","year":"1983","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.pt.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1021\/jo00148a043","article-title":"Structure of a new antifungal antibiotic, irumamycin","volume":"47","author":"\u014cmura","year":"1982","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.pt.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7164\/antibiotics.34.259","article-title":"A new antibiotic, stubomycin","volume":"34","author":"Umezawa","year":"1981","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.pt.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1099\/ijs.0.02692-0","article-title":"Streptomyces scabrisporus sp. nov","volume":"54","author":"Ping","year":"2004","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.pt.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/314642a0","article-title":"Production of \u2018hybrid\u2019 antibiotics by genetic engineering","volume":"314","author":"Hopwood","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.pt.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1099\/00207713-52-6-2163","article-title":"Streptomyces avermectinius sp. nov., an avermectin-producing strain","volume":"52","author":"Takahashi","year":"2002","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.pt.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","article-title":"Avermectins, new family of potent anthelmintic agents: producing organisms and fermentation","volume":"15","author":"Burg","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.15.3.368","article-title":"Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties","volume":"15","author":"Miller","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/AAC.15.3.372","article-title":"Avermectins, new family of potent anthelmintic agents: efficacy of the B1A component","volume":"15","author":"Egerton","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2005.01.005_bib15","series-title":"Macrolide Antibiotics \u2013 Chemistry, Biology, and Practice","first-page":"571","article-title":"Mode of action of avermectin","author":"\u014cmura","year":"2002"},{"year":"1995","series-title":"Twelfth Programme Report. Tropical Disease Research: Progress 1975\u201394, Highlights 1993\u201394","author":"Anon","key":"10.1016\/j.pt.2005.01.005_bib16"},{"key":"10.1016\/j.pt.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(82)91026-1","article-title":"Efficacy and tolerance of ivermectin in human onchocerciasis","volume":"2","author":"Aziz","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0140-6736(82)91350-2","article-title":"Ivermectin in onchocerciasis","volume":"2","author":"Aziz","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6308762","article-title":"Ivermectin: a potent new antiparasitic agent","volume":"221","author":"Campbell","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.pt.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1179\/000349802125000673","article-title":"APOC's strategy of community-directed treatment with ivermectin (CTDI) and its potential for providing additional health services to the poorest populations","volume":"96","author":"Homeida","year":"2002","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.pt.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"12215","DOI":"10.1073\/pnas.211433198","article-title":"Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites","volume":"98","author":"\u014cmura","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nbt820","article-title":"Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis","volume":"21","author":"Ikeda","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pt.2005.01.005_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2883-2-2","article-title":"Final report of the Conference on the eradicability of Onchocerciasis","volume":"2","author":"Dadzie","year":"2003","journal-title":"Filaria. J."},{"key":"10.1016\/j.pt.2005.01.005_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2458-1-12","article-title":"Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination","volume":"1","author":"Alley","year":"2001","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pt.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1073\/pnas.0307757100","article-title":"Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages","volume":"101","author":"Namatame","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2005.01.005_bib26","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.232562799","article-title":"Suppression of bone resorption by madindoline A, a novel non-peptide antagonist to gp130","volume":"99","author":"Hayashi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149220500022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149220500022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T22:00:34Z","timestamp":1734904834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149220500022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S147149220500022X"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2005.01.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"type":"print","value":"1471-4922"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}